Bagalanon, Baby Girl .
HRN: 29-18-42 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/20/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/20/2026
06/27/2026
IV
40mg
Q24h
T/c Neonatal Sepsis
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: